Pediatrix Medical Group - MD Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $16.42
  • Forecasted Upside: 16.51%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$14.09
▼ -0.16 (-1.12%)

This chart shows the closing price for MD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Pediatrix Medical Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MD

Analyst Price Target is $16.42
▲ +16.51% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Pediatrix Medical Group in the last 3 months. The average price target is $16.42, with a high forecast of $18.00 and a low forecast of $15.00. The average price target represents a 16.51% upside from the last price of $14.09.

This chart shows the closing price for MD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 6 investment analysts is to hold stock in Pediatrix Medical Group. This rating has held steady since November 2023, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/30/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
6/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
9/22/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/21/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/16/2024MacquarieInitiated CoverageOutperform$18.00
11/19/2024MizuhoBoost TargetNeutral ➝ Neutral$13.00 ➝ $15.00
11/5/2024UBS GroupBoost TargetNeutral ➝ Neutral$10.50 ➝ $16.50
11/5/2024Jefferies Financial GroupBoost TargetBuy ➝ Buy$14.00 ➝ $18.00
11/4/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$9.00 ➝ $15.00
11/4/2024Truist FinancialBoost TargetHold ➝ Hold$13.00 ➝ $16.00
11/4/2024MizuhoBoost TargetNeutral ➝ Neutral$13.00 ➝ $15.00
10/7/2024Truist FinancialBoost TargetHold ➝ Hold$10.00 ➝ $13.00
9/26/2024Jefferies Financial GroupUpgradeHold ➝ Buy$8.00 ➝ $14.00
8/15/2024Truist FinancialBoost TargetHold ➝ Hold$8.00 ➝ $10.00
8/9/2024UBS GroupBoost TargetNeutral ➝ Neutral$9.00 ➝ $10.50
7/15/2024Truist FinancialLower TargetHold ➝ Hold$10.00 ➝ $8.00
6/7/2024Deutsche Bank AktiengesellschaftUpgradeSell ➝ Hold$8.00 ➝ $8.00
5/15/2024Truist FinancialReiterated RatingHold ➝ Hold$10.00 ➝ $10.00
3/6/2024Jefferies Financial GroupLower TargetHold ➝ Hold$10.00 ➝ $9.00
2/21/2024MizuhoLower TargetNeutral ➝ Neutral$10.00 ➝ $9.00
2/21/2024Truist FinancialLower TargetHold ➝ Hold$10.50 ➝ $10.00
11/30/2023UBS GroupInitiated CoverageNeutral$9.50
10/11/2023Truist FinancialLower TargetHold ➝ Hold$16.00 ➝ $15.00
5/9/2023Truist FinancialLower Target$17.00 ➝ $15.00
5/3/2023Deutsche Bank AktiengesellschaftLower Target$15.50 ➝ $14.00
5/3/2023MizuhoLower Target$17.00 ➝ $15.00
2/22/2023Credit Suisse GroupLower TargetOutperform$27.00 ➝ $23.00
12/5/2022Credit Suisse GroupLower TargetOutperform$28.00 ➝ $27.00
11/16/2022MizuhoLower TargetNeutral$21.00 ➝ $17.00
11/4/2022Leerink PartnersLower TargetMarket Perform$20.00 ➝ $16.00
11/3/2022William BlairReiterated RatingOutperform
8/11/2022Credit Suisse GroupLower TargetOutperform$30.00 ➝ $28.00
8/10/2022BMO Capital MarketsLower TargetMarket Perform$25.00 ➝ $23.00
5/10/2022Deutsche Bank AktiengesellschaftLower Target$24.00 ➝ $16.00
5/2/2022MizuhoLower Target$28.00 ➝ $23.00
2/23/2022Credit Suisse GroupLower TargetOutperform$32.00 ➝ $31.00
12/22/2021Credit Suisse GroupLower TargetOutperform$33.00 ➝ $32.00
11/4/2021Leerink PartnersLower TargetMarket Perform$29.00 ➝ $27.00
11/1/2021BMO Capital MarketsLower TargetMarket Perform$37.00 ➝ $31.00
10/13/2021Truist FinancialLower TargetHold$37.00 ➝ $31.00
9/27/2021Leerink PartnersInitiated CoverageMarket Perform$29.00
8/9/2021Truist FinancialBoost TargetHold$32.00 ➝ $37.00
8/9/2021MizuhoBoost TargetNeutral$30.00 ➝ $32.00
6/22/2021Stifel NicolausInitiated CoverageHold
5/10/2021Deutsche Bank AktiengesellschaftBoost TargetSell$17.50 ➝ $24.00
5/10/2021MizuhoBoost TargetNeutral$20.00 ➝ $30.00
4/14/2021Truist FinancialBoost Target$22.00 ➝ $28.00
2/25/2021Credit Suisse GroupLower TargetOutperform$26.00 ➝ $25.00
2/19/2021CitigroupLower Target$24.00 ➝ $22.00
2/19/2021Deutsche Bank AktiengesellschaftBoost TargetSell$14.00 ➝ $17.50
1/5/2021Truist FinancialBoost Target$20.00 ➝ $26.00
10/19/2020Deutsche Bank AktiengesellschaftDowngradeHold ➝ Sell$20.00 ➝ $12.00
10/6/2020UBS GroupBoost TargetSell$11.00 ➝ $14.00
6/8/2020BMO Capital MarketsBoost Target$16.00 ➝ $20.00
6/8/2020Credit Suisse GroupBoost TargetOutperform$20.00 ➝ $24.00
5/29/2020MizuhoLower TargetNeutral$19.00 ➝ $17.00
5/21/2020SunTrust BanksBoost TargetHold$15.00 ➝ $17.00
5/11/2020CfraLower TargetHold$22.00 ➝ $15.00
5/11/2020Credit Suisse GroupLower TargetOutperform$22.00 ➝ $20.00
5/8/2020UBS GroupLower TargetSell$18.00 ➝ $11.00
5/8/2020Deutsche Bank AktiengesellschaftLower Target$24.00 ➝ $15.00
4/21/2020Robert W. BairdLower TargetNeutral$21.00 ➝ $16.00
4/13/2020SunTrust BanksLower TargetHold$22.00 ➝ $15.00
3/26/2020Credit Suisse GroupLower TargetOutperform$29.00 ➝ $22.00
3/3/2020Robert W. BairdLower TargetNeutral$24.00 ➝ $21.00
2/24/2020JPMorgan Chase & Co.Lower TargetNeutral$33.00 ➝ $20.00
2/24/2020Credit Suisse GroupLower TargetOutperform$33.00 ➝ $29.00
2/21/2020CitigroupLower TargetNeutral$29.00 ➝ $23.00
2/21/2020MizuhoLower TargetNeutral$25.00 ➝ $22.00
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$34.00
1/3/2020CitigroupDowngradeBuy ➝ Neutral$29.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

1.00 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
5/25/2024
  • 6 very positive mentions
  • 5 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
6/24/2024
  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/24/2024
  • 6 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/23/2024
  • 7 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/22/2024
  • 8 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/22/2024
  • 8 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/21/2024
  • 12 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/21/2024

Current Sentiment

  • 12 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Pediatrix Medical Group logo
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Read More

Today's Range

Now: $14.09
Low: $14.01
High: $14.69

50 Day Range

MA: $14.19
Low: $12.30
High: $16.06

52 Week Range

Now: $14.09
Low: $6.62
High: $16.41

Volume

5,048,381 shs

Average Volume

869,270 shs

Market Capitalization

$1.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57

Frequently Asked Questions

What sell-side analysts currently cover shares of Pediatrix Medical Group?

The following Wall Street research analysts have issued stock ratings on Pediatrix Medical Group in the last twelve months: Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., Macquarie, Mizuho, StockNews.com, TheStreet, Truist Financial Co., and UBS Group AG.
View the latest analyst ratings for MD.

What is the current price target for Pediatrix Medical Group?

0 Wall Street analysts have set twelve-month price targets for Pediatrix Medical Group in the last year. Their average twelve-month price target is $16.42, suggesting a possible upside of 16.5%. Macquarie has the highest price target set, predicting MD will reach $18.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $15.00 for Pediatrix Medical Group in the next year.
View the latest price targets for MD.

What is the current consensus analyst rating for Pediatrix Medical Group?

Pediatrix Medical Group currently has 4 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MD, but not buy more shares or sell existing shares.
View the latest ratings for MD.

What other companies compete with Pediatrix Medical Group?

How do I contact Pediatrix Medical Group's investor relations team?

Pediatrix Medical Group's physical mailing address is 1301 CONCORD TERRACE, SUNRISE FL, 33323. The company's listed phone number is (954) 384-0175 and its investor relations email address is [email protected]. The official website for Pediatrix Medical Group is www.mednax.com. Learn More about contacing Pediatrix Medical Group investor relations.